1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. GLENMARK PHARMACEUTICALS LTD.
Glenmark Pharmaceuticals Ltd. NSE: GLENMARK | BSE: 532296

Glenmark Pharma Live Share Price Today, Share Analysis and Chart

Mid-range Performer
In 2 Starfolio Baskets
about

Incorporated in 1977, Glenmark Pharmaceuticals is engaged in the business of development, manufacturing and marketing of pharmaceutical products. The company products in key therapeutic areas includes dermatology, respiratory, oncology, cardiology, d...

Read More
1967.70 -29.50 (-1.48%)
54.27% Gain from 52W Low
429.6K
NSE+BSE Volume

NSE 23 Jan, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Glenmark Pharma is on 30 Jan 2026 for the purpose of Quarterly Results See details
Loading... You have run out of DVM views!
Subscribe now to see details
Durability score
High Financial Strength
- / 100
Valuation Score
Mid Valuation
- / 100
Momentum Score
Technically Neutral
47.2 / 100
Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM
Analyst Price Target
2,199
1Yr Price target upside is 12%
12 analysts

20

S

7

W

3

O

1

T

SWOT Analysis

Glenmark Pharma Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..
Is Glenmark Pharmaceuticals Ltd. worth buying?
580 Votes:
Buy 79.48%
Sell 13.62%
Hold 6.9%
BUY
SELL
HOLD